Dementia: a UCL priority
UCL has worked at the frontiers of brain science for over three decades, and we are home to one of the largest groups of neuroscience experts globally. Our dementia research and expertise span the full spectrum from discovery science through to the evaluation of health and social care.
What is dementia?
According to the World Health Organization over 55 million people have dementia worldwide. This is predicted to triple, rising to over 150 million by 2050.
Dementia is a group of symptoms caused by different diseases that damage the brain. It is a progressive condition which can affect memory, language and behaviour. Currently there is no cure.
While Alzheimer's is the most common type of dementia, there are others such as vascular dementia, frontotemporal dementia, Parkinson's and Huntington’s disease. There are also rarer forms of dementia caused by other diseases and conditions.
How is UCL tackling the global challenge?
Dementia represents one of the toughest scientific and socio-economic challenges facing our society today. UCL is here to change this by focusing our world-leading expertise on cure, prevention and care.
We are home to the national headquarters of the UK Dementia Research Institute (UK DRI), which is the single biggest investment the UK has ever made in dementia, primarily supported by the Medical Research Council, Alzheimer’s Research UK and the Alzheimer’s Society. The creation of UCL's new centre of excellence for neuroscience on Grays Inn Road will bring together the UCL Queen Square Institute of Neurology, the UK DRI headquarters and the UCLH National Hospital for Neurology and Neurosurgery under one roof with the aim of accelerating the treatment of neurological diseases.
Multidisciplinary thinking and collaboration to drive progress
We work in collaboration with the NHS and people affected by dementia, as well as with charities and academic and industry partners across the world, to share knowledge, co-develop research and drive progress.
Translating research discoveries into breakthrough treatments
We research the molecular and cellular basis of neurodegenerative conditions that give rise to dementia to help us identify therapeutic targets. Our cutting-edge technology and state-of-the-art facilities support our researchers in fast-tracking the development of new treatments.
Preventing dementia
We identify modifiable risk factors for neurodegenerative conditions and investigate how behavioural change and large-scale public health interventions can help. We also use brain imaging and biochemical markers to understand how we can prevent dementia before symptoms appear.
Revolutionising care for those with dementia
At the heart of our work are those affected by dementia, as well as their carers and families. We focus on how to provide the best clinical care for patients and ensure that access to information, advice and support is available to everyone.
Training the next generation of dementia researchers
We are equipping the next generation of scientists and clinicians with the capability and technology they need to develop breakthrough cures and treatments that will enable us to conquer the challenge of dementia once and for all.
UCL Giving - support our work